Danaher Corporation (DHR)
undefined
undefined%
At close: undefined
238.20
0.06%
After-hours Jan 06, 2025, 07:00 PM EST

Company Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide.

The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.

The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers.

The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products.

This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings.

The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications.

This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products.

The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.

Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Danaher Corporation
Danaher Corporation logo
Country United States
IPO Date Dec 29, 1978
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 61,000
CEO Rainer M. Blair

Contact Details

Address:
2200 Pennsylvania Avenue, NW
Washington, DC
United States
Website https://www.danaher.com

Stock Details

Ticker Symbol DHR
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000313616
CUSIP Number 235851102
ISIN Number US2358511028
Employer ID 59-1995548
SIC Code 3823

Key Executives

Name Position
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Brian W. Ellis J.D. Senior Vice President, General Counsel & Chief Compliance Officer
Christopher M. Bouda Vice President & Chief Accounting Officer
Daniel A. Raskas J.D. Senior Vice President of Corporate Development
Dr. Jose-Carlos Gutierrez-Ramos Ph.D. Senior Vice President & Chief Science Officer
Georgeann F. Couchara Senior Vice President of Human Resources
John Bedford Vice President of Investor Relations
Mitchell P. Rales Co-Founder & Director
Steven M. Rales Co-Founder & Chairman

Latest SEC Filings

Date Type Title
Dec 19, 2024 4 Filing
Dec 11, 2024 8-K Current Report
Nov 27, 2024 4 Filing
Nov 22, 2024 4 Filing
Nov 22, 2024 4 Filing
Nov 22, 2024 4 Filing
Nov 18, 2024 4 Filing
Nov 18, 2024 4 Filing
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 28, 2024 4 Filing